QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
NASDAQ:AMPH

Amphastar Pharmaceuticals Earnings Date, Estimates, & History

$19.10
-0.09 (-0.47 %)
(As of 10/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$18.90
$19.28
50-Day Range
$17.83
$20.32
52-Week Range
$16.91
$21.63
Volume98,696 shs
Average Volume189,369 shs
Market Capitalization$917.41 million
P/E Ratio90.96
Dividend YieldN/A
Beta0.74

Earnings Summary

Upcoming
Earnings Date
Nov. 5
Estimated

Actual EPS
(Aug. 8)
$0.21

Consensus EPS
(Aug. 8)
$0.21

Last Year's Q3 EPS
(8/6/2020)
$0.16

Skip Charts & View Estimated and Actual Earnings Data

Amphastar Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Amphastar Pharmaceuticals Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Amphastar Pharmaceuticals (NASDAQ:AMPH) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212$0.15$0.20$0.18
Q2 20212$0.22$0.25$0.24
Q3 20212$0.28$0.29$0.29
Q4 20212$0.32$0.35$0.34
FY 20218$0.97$1.09$1.03
Q1 20221$0.29$0.29$0.29
Q3 20221$0.35$0.35$0.35

AMPH Earnings Information

Amphastar Pharmaceuticals last released its quarterly earnings data on August 8th, 2021. The reported $0.21 EPS for the quarter, meeting analysts' consensus estimates of $0.21. The business earned $101.66 million during the quarter, compared to analysts' expectations of $101.38 million. Amphastar Pharmaceuticals has generated $0.64 earnings per share over the last year ($0.21 diluted earnings per share) and currently has a price-to-earnings ratio of 91.0. Earnings for Amphastar Pharmaceuticals are expected to grow by 59.49% in the coming year, from $0.79 to $1.26 per share. Amphastar Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 5th, 2021 based off prior year's report dates.

Amphastar Pharmaceuticals (NASDAQ:AMPH) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
11/5/2021
(Estimated)
        
8/8/20216/30/2021$0.21$0.21$0.26$101.38 million$101.66 million      
5/6/20213/31/2021$0.19$0.27+$0.08$0.44$97.12 million$103.02 million  
3/14/202112/31/2020$0.14$0.16+$0.02$0.45$89.29 million$95.92 million    
11/11/20209/30/2020$0.14$0.15+$0.01$0.10$90.81 million$83.43 million    
8/6/2020Q2 2020$0.11$0.16+$0.05$0.32$84.30 million$85.81 million  
5/7/20203/31/2020$0.09$0.17+$0.08$0.26$81.80 million$84.69 million    
3/12/202012/31/2019$0.05$0.07+$0.02$0.16$80.28 million$83.38 million    
11/7/2019Q3$0.08$0.10+$0.02$0.17$78.53 million$80.14 million    
8/7/2019Q2 2019$0.03$0.08+$0.05($0.80)$78.90 million$79.00 million  
5/9/20193/31/2019$0.03$0.10+$0.07$0.18$76.21 million$79.79 million  
3/12/201912/31/2018$0.11$0.13+$0.02$0.22$75.46 million$89.69 million  
11/8/20189/30/2018$0.11$0.12+$0.01$0.19$76.84 million$75.54 million  
8/8/2018Q2 2018$0.08$0.03($0.05)$0.12$64.22 million$71.00 million
5/9/2018Q1 2018$0.08($0.05)($0.13)$0.06$60.75 million$58.40 million
3/12/2018Q4 2017$0.07$0.10+$0.03$0.17$60.62 million$60.40 million  
11/8/2017Q3 2017$0.02$0.07+$0.05$0.14$57.23 million$57.90 million
8/9/2017Q2 2017$0.06$0.11+$0.05$0.18$63.40 million$65.20 million  
5/8/2017Q1 2017$0.06$0.03($0.03)$0.04$63.74 million$56.67 million  
3/13/2017Q4 2016($0.01)$0.01+$0.02($0.06)$55.78 million$63.54 million
11/8/2016Q3$0.03$0.14+$0.11$0.08$65.12 million$64.20 million  
8/8/2016Q2$0.01$0.23+$0.22$0.13$62.10 million$68.00 million
5/9/2016Q1($0.03)$0.12+$0.15$0.07$62.00 million$59.40 million
3/14/2016Q415($0.04)$0.19+$0.23$0.16$64.48 million$76.90 million
11/12/2015Q315($0.20)($0.01)+$0.19($0.07)$19.49 million$63.90 million  
8/12/2015Q215($0.11)($0.09)+$0.02($0.13)$19.49 million$53.85 million  
5/13/2015Q115($0.17)($0.01)+$0.16($0.07)$45.87 million$56.89 million  
3/24/2015Q414($0.06)($0.03)+$0.03($0.06)$54.90 million$55.90 million
11/12/2014Q314($0.11)($0.11)($0.10)$45.89 million$59.70 million
8/12/2014Q2 2014($0.11)$0.02+$0.13$0.07$44.23 million$49.00 million  
(Earnings results data provided by Zacks Investment Research)












Amphastar Pharmaceuticals (NASDAQ:AMPH) Earnings Frequently Asked Questions

When is Amphastar Pharmaceuticals's earnings date?

Amphastar Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 5th, 2021 based off last year's report dates. Learn more on AMPH's earnings history

Did Amphastar Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Amphastar Pharmaceuticals (NASDAQ:AMPH) reported $0.21 earnings per share (EPS) to hit the analysts' consensus estimate of $0.21. Learn more on AMPH's earnings details

How can I listen to Amphastar Pharmaceuticals's earnings conference call?

The conference call for Amphastar Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Amphastar Pharmaceuticals's conference call transcript?

The conference call transcript for Amphastar Pharmaceuticals's latest earnings report can be read online. Read Transcript

How can I view Amphastar Pharmaceuticals's earnings report?

Amphastar Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Amphastar Pharmaceuticals generate each year?

Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded annual revenue of $349.85 million.

How much profit does Amphastar Pharmaceuticals generate each year?

Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded net income of $1.40 million. AMPH has generated $0.64 earnings per share over the last four quarters.

What is Amphastar Pharmaceuticals's price-to-earnings ratio?

Amphastar Pharmaceuticals (NASDAQ:AMPH) has a trailing price-to-earnings ratio of 90.96 and a forward price-to-earnings ratio of 24.18.

What is Amphastar Pharmaceuticals's EPS forecast for next year?

Amphastar Pharmaceuticals's earnings are expected to grow from $0.79 per share to $1.26 per share in the next year, which is a 59.49% increase.

This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.